Raf-induced transformation requires an interleukin 1 autocrine loop

Cancer Research

Volumn 61, Issue 2, 2001, Pages 602-607

  Vale, Terry ^a   Ngo, Teri T ^a   White, Michael A ^a   Lipsky, Peter E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RESPONSE MODIFIER A; GENE PRODUCT; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; AUTOCRINE COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; DNA, RECOMBINANT; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PLASMIDS; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 0035863394     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Activation of mitogen-activated protein kinase-kinase by v-Raf in NIH 3T3 cells and in vitro
2. Activation of the MAP kinase pathway by the protein kinase Raf
3. Raf-1 activates MAP kinase-kinase
4. Serum-, TPA-, and Ras-induced expression from AP-I/Ets-driven promoters requires Raf-1 kinase
5. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1
6. Raf-1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation
7. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway
8. Rel/NF-κB and IκB proteins: An overview
9. The crystal structure of the IκB/NF-κB complex reveals mechanisms of NF-κB inactivation
10. Structure of an IκB/NF-κB complex
11. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
12. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
13. Identification and characterization of an IκB kinase
14. IκB kinase-β NF-κB activation and complex formation with IκB kinase α and NIK
15. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
16. Direct phosphorylation of IκB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate
17. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
18. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and nonconsensus CRE-like site
19. Biologic basis for interleukin-1 in disease
20. Characterization of a functional NF-κB site in the human interleukin 1β promoter: Evidence for a positive autoregulatory loop
21. Stopping the cuts: Cytokine-processing enzymes
22. Cloning, sequence, and expression of two distinct human interleukin-1 complementary DNAs
23. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β
24. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
25. Phospbatidylinositol 3-kinase in interleukin 1 signaling
26. IRAK. A kinase associated with the intedeukin-1 receptor
27. IRAK (Pelle) family members IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
28. TRAF6 is a signal transducer for intefleukin-1
29. Multiple Ras functions can contribute to mammalian cell transformation
30. Inhibition of NF-κB by sodium salicylate and aspirin
31. Transformation of mammalian cells by constitutively active MAP kinase-kinase
32. Coupling of a signal response domain in IκB to multiple pathways for NF-κB activation
33. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
34. Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1
35. Ras target proteins in eukaryotic cells
36. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
37. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras
38. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers
39. Angiotensin II type I receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism
40. Mechanisms regulating Raf-1 activity in signal transduction pathways
41. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
42. Characterization of IκB kinases
43. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex
44. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade
45. Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
46. Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade
47. MEKK1 activates both IκB kinase α and IκB kinase β
48. NF-κB-inducing kinase activates IKKα by phosphorylation of Ser-176
49. Insulin activates nuclear factor κB in mammalian cells through a Raf-I-mediated pathway
50. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2)
51. The NF-κB/Rel and IκB gene families: Mediators of immune response and inflammation
52. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro
53. Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1α
54. Suppression of chronic myelogenous leukemia colony growth by IL-1 receptor antagonist and soluble IL-1 receptors: A novel mechanism of chronic myelogenous leukemia progression
55. Oncogenes: Clinical relevance
56. Progress in understanding the molecular pathogenesis of human lung cancer